Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - lincomycin hydrochloride monohydrate equivalent to 500 mg lincomycin base;   - capsule - 500 mg - active: lincomycin hydrochloride monohydrate equivalent to 500 mg lincomycin base   excipient: lactose monohydrate magnesium stearate purified talc

Canada - inglese - Health Canada

pfizer canada ulc - lincomycin (lincomycin hydrochloride) - capsule - 500mg - lincomycin (lincomycin hydrochloride) 500mg - lincomycins

Belgio - inglese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - lincomycin hydrochloride - eq. lincomycin 500 mg - capsule, hard - 500 mg - lincomycin hydrochloride - lincomycin

Filippine - inglese - FDA (Food And Drug Administration)

pfizer inc - usa - lincomycin (as hydrochloride) - capsule - 500mg

Arabia Saudita - inglese - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharmacia upjohn - lincomycin - capsule - 500 mg

Namibia - inglese - Namibia Medicines Regulatory Council

pfizer laboratories (pty) ltd - lincomycin hcl - capsule - each capsule contains lincomycin hcl equiv. to lincomycin base 500 mg

Giappone - inglese - すりの適正使用協議会 RAD-AR Council, Japan

pfizer pharmaceuticals inc. - lincomycin hydrochloride hydrate - dark blue opaque/pale blue opaque capsule

Australia - inglese - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - lincomycin hydrochloride monohydrate, quantity: 340.26 mg/ml (equivalent: lincomycin, qty 300 mg/ml) - injection, solution - excipient ingredients: benzyl alcohol; water for injections - indications as at 22 september 1994: lincocin is indicated in the treatment of serious infections due to susceptible strains of gram positive aerobes such as streptococci, pneumococci and staphylococci. its use should be reserved for penicillin allergic patients or other patients for whom, in the judgement of the physician, a penicillin is inappropriate. because of the risk of colitis (see precautions), before selecting lincomycin the physician should consider the nature of infection and the suitability of less toxic alternatives (e.g.erythromycin). lincocin has been demonstrated to be effective in the treatment of staphylococcal infections resistant to other antibiotics and susceptible to lincomycin. staphylococcal strains resistant to lincocin have been recovered; culture and susceptibility studies should be done in conjunction with lincocin therapy. in the case of macrolides, partial but not complete cross resistance may occur. the drug may be administered concomitantly with other antimicrobial agents with

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

pharmacia limited - lincomycin hydrochloride - capsule - 500 milligram